BRITISH AIRWAYS, VIRGIN ATLANTIC AND HEATHROW LAUNCH PROVING TRIALS TO SIMPLIFY TRAVEL RULES FOR FULLY VACCINATED CUSTOMERS
The Voice of Chandigarh | Travel Trade Reporter
Fully vaccinated travellers of all nationalities will be able to present their Covid-19 credentials in digital or paper format to help prove vaccination status can be quickly and easily checked away from the border and allow safe entry to the UK
British Airways, Virgin Atlantic and Heathrow have joined forces to prove it’s possible to quickly and easily verify those arriving into the UK who are fully vaccinated – an identification process already in place for outbound travel to several countries. Earlier this week, Germany became the latest country to confirm it would accept fully vaccinated UK travellers without the need to quarantine. The new UK proving trial, enabling inbound travellers to present their fully vaccinated status, will support the Government to move forward with its plans to remove quarantine for double jabbed passengers entering the UK from ‘amber list’ countries.
The initiative will see fully vaccinated volunteers travelling on selected flights from Athens, Los Angeles, Montego Bay and New York to London Heathrow showing proof of their vaccine status. The trial aims to reassure Government that airlines and airports can check vaccine status upstream and away from the Border, ensuring no further pressure in UK immigration halls. Those taking part in the trial will be able to use a dedicated arrivals lane at the border and British Airways customers will be able to access a discounted rate for the mandatory arrivals tests.
Internationally recognized vaccination credentials will be accepted in the proving trial including the NHS app, CDC card, US state-level digital certification and EU Digital Covid Credential. British Airways will also support customers’ vaccine verification through the VeriFLY app and Virgin Atlantic customers can verify their vaccine certificate through a new digital uploader tool, developed in partnership with Delta Air Lines and backed by TrustAssure™ technology. As the proof-of-concept develops, the options for customers to show vaccine status will rapidly be expanded, across physical, digital and integrated formats, including IATA Travel Pass.
The UK has led the world with its successful vaccine programme, which the Government promised would lead to the end of Covid restrictions. To date, 86% of UK adults have had the first dose of a Covid vaccine, with 64% fully vaccinated. Data from Public Health England has shown two doses of the vaccines offer 79% protection against becoming ill from the Delta variant and reduces the likelihood of needing hospitalization by 96%.
Despite this incredible achievement the UK is failing to reap the economic and social rewards, falling behind countries like France, Germany, Greece, Portugal, Cyprus and Malta, all of which accept fully vaccinated travellers, including US residents, without the need for quarantine. The US also allows its fully vaccinated residents to avoid self-isolation. The Government’s own transparency data also continue to show very low positivity in test results from ‘green’ and ‘amber’ country arrivals, with just 0.4% testing positive, and none of them had a variant of concern.
Sean Doyle, British Airways CEO and Chairman said: “We need to act quickly to protect jobs, re-build the UK economy and reunite loved ones. We are already helping our customers show proof of their vaccination status when travelling to a number of other countries outside the UK that require it, and we’re confident we can make this happen for entry to Britain too, very quickly. We look forward to providing the data that proves it’s simple for fully vaccinated status to be verified and to the Government meeting its commitment to get the country moving again.” In the US, more than 157m people have been fully vaccinated – including 58% of US adults – with domestic flying returning to pre-pandemic levels, proving that flying is safe.
Shai Weiss, CEO, Virgin Atlantic said: “To reap the benefits of the UK’s world-leading vaccine rollout, the UK Government must act now to remove self-isolation for fully vaccinated passengers arriving from ‘amber’ countries, and no later than the domestic reopening on 19th July. Our proof-of-concept trial on selected US and Caribbean routes demonstrates our readiness as an industry to rapidly operationalize the new policy, and work with Government and authorities to ensure it is smoothly implemented at pace, supporting the reopening of the Transatlantic corridor, without which £23m is lost each day from the UK economy.“The UK is already falling behind US and EU and a continued overly cautious approach towards international travel will further impact the economic recovery and the 500,000 UK jobs that are at stake.”Representatives from the travel industry have been clear about the consequences for the UK’s economy and jobs of not opening the corridor quickly enough, with hundreds taking part in a day of action on June 23. Heathrow released new research from CEBR, reinforcing the importance of aviation to the Government’s ambitions for Global Britain, which could help the industry deliver a £204bn trade boost to benefit every corner of the UK. Heathrow has warned that this cannot be realized unless the UK’s aviation industry is supported by Government policies to resume flying as soon as possible. By capitalizing on the country’s vaccine dividend, ministers can help to deliver this economic stimulus for exporters across Britain, ensuring the UK retains its competitive edge as the country comes out of lockdown. On Monday, Prime Minister Boris Johnson restated that this important step to exempt fully vaccinated travellers from self-isolation would happen ‘later this summer, with Transport Secretary Grant Shapps set to provide more detail this week. It’s hoped the proof-of-concept will encourage the Government to introduce exemptions for fully vaccinated travellers no later than 19 July, allowing the UK to catch up with the EU and US, which have already introduced similar schemes.